البحث | All Crowdz

Nikita Girmal أضاف وظيفة جديدة أخرى
2026-01-22 10:11:43 -

Gene Therapy for Rare Disease Market to Grow at a CAGR of 35.5% Through 2032
“According to a new report published by Introspective Market Research, Gene Therapy for Rare Disease Market by Therapy Type, Vector Type, and Indication, The Global Gene Therapy for Rare Disease Market Size Was Valued at USD 101.5 Billion in 2023 and is Projected to Reach USD 2,869.54 Billion by 2032, Growing at a CAGR of 35.5% from 2024–2032.” Gene therapy for rare diseases...

0 التعليقات 0 المشاركات 378 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Vikas Kokate أضاف وظيفة جديدة أخرى
2025-07-30 12:10:29 -

Cushing's Disease Market Overview, Growth Analysis, Trends and Forecast By 2029
"Executive Summary Cushing's Disease Market : Data Bridge Market Research analyses that the Cushing's disease market was valued at USD 333.80 million in 2021 and is expected to reach USD 686.89 million by 2029, registering a CAGR of 9.44% during the forecast period of 2022 to 2029. The Cushing's Disease Market report highlights the global key manufacturers to define, describe and...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Ksh Dbmr أضاف وظيفة جديدة Networking
2026-03-09 08:19:19 -

How Is the Essential Thrombocytosis Treatment Market Advancing Rare Blood Disorder Care?
Detailed Analysis of Executive Summary Essential Thrombocytosis Treatment Market Size and Share CAGR Value The global essential thrombocytosis treatment market size was valued at USD 968.50 Million in 2025 and is expected to reach USD 1509.03 Million by 2033, at a CAGR of 5.70% during the forecast period The Essential Thrombocytosis Treatment report provides market shares at global...

0 التعليقات 0 المشاركات 239 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Vanshika Swami أضاف وظيفة جديدة Health
2026-03-05 10:38:43 -

Neurofibromatosis Drugs Market Outlook 2026–2034: 14.1% CAGR Forecast, Emerging Treatment Trends & Growth Analysis
Neurofibromatosis drugs are pharmaceutical treatments that help control tumor growth and manage complications caused by the condition. These medications support symptom management and improve patient care. Neurofibromatosis Drugs Market Size and Growth Outlook (2026–2034) The global Neurofibromatosis Drugs Market size is projected to reach US$ 12.34 billion by 2034 from US$...

0 التعليقات 0 المشاركات 232 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!